Achieving clinical success with BET inhibitors as anti-cancer agents
British journal of cancer, 2021-04, Vol.124 (9), p.1478-1490 [Peer Reviewed Journal]The Author(s) 2021. This work is published under http://creativecommons.org/licenses/by/4.0/ (the “License”). Notwithstanding the ProQuest Terms and Conditions, you may use this content in accordance with the terms of the License. ;The Author(s) 2021 ;ISSN: 0007-0920 ;EISSN: 1532-1827 ;DOI: 10.1038/s41416-021-01321-0 ;PMID: 33723398
Full text available